Keyword: Corindus Vascular Robotics
Corindus Vascular Robotics reported that it has completed its first machine-assisted brain surgery procedure in humans.
Siemens’ medical solutions subsidiary will acquire all issued and outstanding shares of Corindus’ common stock for $4.28 per share.
Here's Monday's other medtech news of note.
Corindus sees the software update expanding use of percutaneous coronary intervention technology CorPath GRX to more complex procedures.